BOSUTRIS 500MG TABLET

Form: Tablets

Pack Size: 30 TABLETS

Marketed by: MYLAN PHARMACEUTICALS PVT LTD (ONCOLOGY DIV)

MRP: ₹5738.28

MYLAN PHARMACEUTICALS PVT LTD (ONCOLOGY DIV): Bosutris 500MG Tablet, 30 tablets, salt bosutinib 500mg. NPPA has revised its MRP from Rs 10,312 to Rs 5,738.28 (44% lower) with effect from 09-11-2026; trade rate Rs 4,372.02. Group: BCR-ABL tyrosine kinase inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: taken with food; diarrhoea is common in the first weeks. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.